YaoGeJu

Company directoryChina company filings

Jiangsu Yunyang Group Pharmaceutical Co.,Ltd.

As of 20 November 2026, for the company name Jiangsu Yunyang Group Pharmaceutical Co.,Ltd. as recorded, 1 application with this name as first applicant is listed as under review at China's CDE; the CDE acceptance records name it as first applicant on 6 records, across 4 drug names; since 24 August 2026, the records list Accepted: 1 application; the chemical-drug catalogue lists 2 active records with this name as holder; 19 active API registrations list this name as first registered company; 18 further acceptance records name it after the first applicant.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/20
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/20.

Drug filings

6 acceptance records as first applicant, grouped into 4 source drug names. Source data as of 2026/11/20.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

愈美片 · No verified English name 1 records · Latest accepted 2026/09/24

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2601810Supplement2026/09/24Jiangsu Yunyang Group Pharmaceutical Co.,Ltd.CDE ↗
Arginine and Ibuprofen Granules 3 records · Latest accepted 2025/05/16

Supplement · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2500987Supplement2025/05/16Jiangsu Yunyang Group Pharmaceutical Co.,Ltd.CDE ↗
CYHB2500985Supplement2025/05/16Jiangsu Yunyang Group Pharmaceutical Co.,Ltd.CDE ↗
CYHB2500983Supplement2025/05/16Jiangsu Yunyang Group Pharmaceutical Co.,Ltd.CDE ↗
Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution 1 records · Latest accepted 2025/05/11

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2500944Supplement2025/05/11Jiangsu Yunyang Group Pharmaceutical Co.,Ltd.CDE ↗
Bromhexine Hydrochloride Tablets 1 records · Latest accepted 2025/02/22

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2550124Supplement2025/02/22Jiangsu Yunyang Group Pharmaceutical Co.,Ltd.CDE ↗

Changes in the last 90 days

1 events from 2026/08/24 to 2026/11/21. CDE data as of 2026/11/20; NMPA data as of 2026/11/20.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Accepted: 1 application

  1. 2026/09/24Accepted

    愈美片 · No verified English name

    CYHB2601810

    Fact date: 2026/09/24 · Date added to this site: 2026/10/21

    View source ↗

Under review

1 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/20.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
愈美片 · No verified English name CYHB2601810Supplement2026/09/24Jiangsu Yunyang Group Pharmaceutical Co.,Ltd.CDE ↗

Catalogue holder records

2 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/20. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerNMPA approval no.ApprovedCatalogue category (source text)View source
Bromhexine Hydrochloride TabletsJiangsu Yunyang Group Pharmaceutical Co.,Ltd.Jiangsu Yunyang Group Pharmaceutical Co.,Ltd.国药准字H320232552026/03/31Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Clozapine TabletsJiangsu Yunyang Group Pharmaceutical Co.,Ltd.Jiangsu Yunyang Group Pharmaceutical Co.,Ltd.国药准字H320233572020/09/04Drug that passed quality-and-efficacy consistency evaluationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

19 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/20.

NameCompany / applicantRegistration numberStatusSource update dateView source
甲基橙皮苷 · No verified English nameJiangsu Yunyang Group Pharmaceutical Co.,Ltd.Y20240000596I2025/05/23CDE ↗
盐酸甲氧氯普胺 · No verified English nameJiangsu Yunyang Group Pharmaceutical Co.,Ltd.Y20230000627A2025/04/30CDE ↗
布美他尼 · No verified English nameJiangsu Yunyang Group Pharmaceutical Co.,Ltd.Y20230000614A2024/11/07CDE ↗
硝唑尼特 · No verified English nameJiangsu Yunyang Group Pharmaceutical Co.,Ltd.Y20220001112I2023/01/10CDE ↗
吗啉硝唑 · No verified English nameJiangsu Yunyang Group Pharmaceutical Co.,Ltd.Y20220000877A2024/11/19CDE ↗
精氨酸布洛芬 · No verified English nameJiangsu Yunyang Group Pharmaceutical Co.,Ltd.Y20220001054A2024/03/15CDE ↗
醋酸阿比特龙 · No verified English nameJiangsu Yunyang Group Pharmaceutical Co.,Ltd.Y20210000347A2022/10/25CDE ↗
依普利酮 · No verified English nameJiangsu Yunyang Group Pharmaceutical Co.,Ltd.Y20200001280A2023/08/11CDE ↗
利伐沙班 · No verified English nameJiangsu Yunyang Group Pharmaceutical Co.,Ltd.Y20200000353A2025/12/24CDE ↗
阿哌沙班 · No verified English nameJiangsu Yunyang Group Pharmaceutical Co.,Ltd.Y20190000972I2019/11/05CDE ↗
左奥硝唑 · No verified English nameJiangsu Yunyang Group Pharmaceutical Co.,Ltd.Y20190021363A2023/10/30CDE ↗
硝酸咪康唑 · No verified English nameJiangsu Yunyang Group Pharmaceutical Co.,Ltd.Y20190006908A2023/03/24CDE ↗
盐酸普萘洛尔 · No verified English nameJiangsu Yunyang Group Pharmaceutical Co.,Ltd.Y20190004980A2025/08/23CDE ↗
盐酸可乐定 · No verified English nameJiangsu Yunyang Group Pharmaceutical Co.,Ltd.Y20190004979A2025/08/05CDE ↗
氯氮平 · No verified English nameJiangsu Yunyang Group Pharmaceutical Co.,Ltd.Y20190004972A2025/07/18CDE ↗
美洛昔康 · No verified English nameJiangsu Yunyang Group Pharmaceutical Co.,Ltd.Y20190004969A2025/08/05CDE ↗
克霉唑 · No verified English nameJiangsu Yunyang Group Pharmaceutical Co.,Ltd.Y20190004934A2026/03/13CDE ↗
盐酸普罗帕酮 · No verified English nameJiangsu Yunyang Group Pharmaceutical Co.,Ltd.Y20190004933A2025/08/30CDE ↗
盐酸莫西沙星 · No verified English nameJiangsu Yunyang Group Pharmaceutical Co.,Ltd.Y20170000704I—CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

18 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/20.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Ursodeoxycholic acid oral suspension CYHB2502344Supplement2025/11/13成都赛璟生物医药科技有限公司; Jiangsu Yunyang Group Pharmaceutical Co.,Ltd.CDE ↗
Levothyroxine Sodium Tablets CYHS2503787Generic2025/10/24Hai Hong Heng Long (Hainan) Bio Technology Co., Ltd. romanized; Jiangsu Yunyang Group Pharmaceutical Co.,Ltd.CDE ↗
Levothyroxine Sodium Tablets CYHS2503786Generic2025/10/24Hai Hong Heng Long (Hainan) Bio Technology Co., Ltd. romanized; Jiangsu Yunyang Group Pharmaceutical Co.,Ltd.CDE ↗
Furosemide Tablets CYHS2503564Generic2025/09/29Hai Hong Heng Long (Hainan) Bio Technology Co., Ltd. romanized; Jiangsu Yunyang Group Pharmaceutical Co.,Ltd.CDE ↗
Ursodeoxycholic acid oral suspension CYHS2302006Generic2023/07/27成都赛璟生物医药科技有限公司; Jiangsu Yunyang Group Pharmaceutical Co.,Ltd.CDE ↗
Arginine and Ibuprofen Granules CYHS2301222Generic2023/05/06Nanjing Cavendish Bio-engineering Technology Co., Ltd.; Jiangsu Yunyang Group Pharmaceutical Co.,Ltd.CDE ↗
Arginine and Ibuprofen Granules CYHS2301221Generic2023/05/06Nanjing Cavendish Bio-engineering Technology Co., Ltd.; Jiangsu Yunyang Group Pharmaceutical Co.,Ltd.CDE ↗
Arginine and Ibuprofen Granules CYHS2301220Generic2023/05/06Nanjing Cavendish Bio-engineering Technology Co., Ltd.; Jiangsu Yunyang Group Pharmaceutical Co.,Ltd.CDE ↗
Ambroxol Hydrochloride Oral Solution CYHS2300569Generic2023/02/18Nanjing Cavendish Bio-engineering Technology Co., Ltd.; Jiangsu Yunyang Group Pharmaceutical Co.,Ltd.CDE ↗
Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution CYHS2300568Generic2023/02/18Nanjing Cavendish Bio-engineering Technology Co., Ltd.; Jiangsu Yunyang Group Pharmaceutical Co.,Ltd.CDE ↗
Rivaroxaban Tablets CYHB2201884Supplement2022/10/14Nanjing Cavendish Bio-engineering Technology Co., Ltd.; Jiangsu Yunyang Group Pharmaceutical Co.,Ltd.CDE ↗
Macitentan Tablets CYHS2201679Generic2022/10/10Nanjing Ze Heng Pharmaceuticals Technology Kai Fa Co., Ltd. romanized; Jiangsu Yunyang Group Pharmaceutical Co.,Ltd.CDE ↗
Eplerenone Tablets CYHS2102151Generic2021/12/17Nanjing Cavendish Bio-engineering Technology Co., Ltd.; Jiangsu Yunyang Group Pharmaceutical Co.,Ltd.CDE ↗
Eplerenone Tablets CYHS2102150Generic2021/12/17Nanjing Cavendish Bio-engineering Technology Co., Ltd.; Jiangsu Yunyang Group Pharmaceutical Co.,Ltd.CDE ↗
Abiraterone Acetate Tablets CYHS2101758Generic2021/09/23Nanjing Cavendish Bio-engineering Technology Co., Ltd.; Jiangsu Yunyang Group Pharmaceutical Co.,Ltd.CDE ↗
Rivaroxaban Tablets CYHS2101095Generic2021/04/23Nanjing Cavendish Bio-engineering Technology Co., Ltd.; Jiangsu Yunyang Group Pharmaceutical Co.,Ltd.CDE ↗
Rivaroxaban Tablets CYHS2101094Generic2021/04/23Nanjing Cavendish Bio-engineering Technology Co., Ltd.; Jiangsu Yunyang Group Pharmaceutical Co.,Ltd.CDE ↗
Rivaroxaban Tablets CYHS2100015Generic2021/01/08Nanjing Cavendish Bio-engineering Technology Co., Ltd.; Jiangsu Yunyang Group Pharmaceutical Co.,Ltd.CDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/20
Chemical-drug catalogue
Last successful update: 2026/11/20
API registrations
Last successful update: 2026/11/20
NMPA drug delivery notices
Last successful update: 2026/11/20

Loaded notices dated 2026-11-06 to 2026-11-20; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.